SaphenionPatientinnenInfo – Das Beckenvenensyndrom hat etwas mit Krampfadern zu tun. Rund 30% aller Frauen mit chronischen Unterbauchschmerzen leiden am Beckenvenensyndrom (Pelvic Congestion Syndrome). Während die medikamentöse Behandlung nur kurzzeitig eine Erleichterung der Symptomatik bringt, liegt der klinische Erfolg der Embolisationstherapie bei bis zu 85 Prozent.
SaphenionScience: Muscle veins – foot varicose veins: In general, varicose vein formation of perforatorveins also causes the anatomical-functional conversion of muscle veins into varicose-vein enlarged and high-venous resting and stress-loaded muscle veins. This has already been shown by us in the impact on the capillary and arterial systemWhat is important, however, is the fact that these perforator veins on the instep and ankle are already created in the normal anatomy and physiology without venous valves!
SaphenionScience: VenaSeal varicose veins: Since 7 years we are working with VenaSeal (Medtronic, Minneapolis), a N-butyl -2 – cyanoacrylate in therapy of truncal varicose veins. Until to today time we treated 2384 truncal veins. The cyanoacrylat – polymer is a high effective vein glue for the treatment of patients with CVI and varicosie veins.As an implanted device, question is important: How long cyanoacrylate persists after using as a vein glue inside the truncal varicose veins.
Saphenion Science – 7 лет Venaseal – применяемый при варикозном расширении вен, химическое вещество (н-бутил-2-цианоакрилат) в течение многих лет входит в программу терапии практически во всех хирургических дисциплинах, например в дерматологии, внутренней медицине, детской хирургии, офтальмологии, ортопедии, хирургии (сосудистой хирургии), нейрорадиологии, челюстно-лицевой хирургии. Начало применения упоминалось уже в 60-е годы. Почти во всех дисциплинах до использования на человеке было проведено применение на животных.
The super glue VenaSeal has been used by Saphenion for nearly 7 years to treat truncal varicose veins. Of course, after the treatment of 1221 patients and 2290 truncal veins, the therapy scheme is also considered.
New Saphenion therapy protocol for superficial vein thrombosis Dr. Ulf Th.Zierau, PD Dr. W. Lahl The Saphenion Therapy Protocol for Phlebitis / Thrombophlebitis / Superficial Vein Thrombosis / Skin Vein […]